| 1 |
30600305 | Immunometabolic Effect of Cholesterol in Hepatitis C Infection: Implications in Clinical Management and Antiviral Therapy. | 2018 Oct 16 |
1 |
| 2 |
24726260 | [Lipid kinetics during dual antiviral therapy in patients with chronic hepatitis C]. | 2015 Jun 22 |
1 |
| 3 |
24553484 | Impact of comorbid hepatic steatosis on treatment of chronic hepatitis C in Japanese patients and the relationship with genetic polymorphism of IL28B, PNPLA3 and LDL receptor. | 2014 |
1 |
| 4 |
24204859 | Association of IFNL3 rs12979860 and rs8099917 with biochemical predictors of interferon responsiveness in chronic hepatitis C virus infection. | 2013 |
1 |
| 5 |
21879313 | Genotype rs8099917 near the IL28B gene and amino acid substitution at position 70 in the core region of the hepatitis C virus are determinants of serum apolipoprotein B-100 concentration in chronic hepatitis C. | 2012 Jan |
1 |
| 6 |
22300408 | Recipient IL28B polymorphism is an important independent predictor of posttransplant diabetes mellitus in liver transplant patients with chronic hepatitis C. | 2012 Mar |
1 |
| 7 |
22431022 | The interleukin 28B rs12979860 C/T polymorphism and serum cholesterol as predictors of fibrosis progression in patients with chronic hepatitis C and persistently normal transaminases. | 2012 May |
2 |
| 8 |
21703198 | Beneficial IL28B genotype associated with lower frequency of hepatic steatosis in patients with chronic hepatitis C. | 2011 Dec |
1 |